Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study

被引：0
|
作者：
Milan Gupta
Rajvi J. Wani
Khalid Al Faraidy
Jean Bergeron
Eduardo Contreras
Angel Alberto Garcia Peña
G. B. John Mancini
Francisco Padilla
Abel Alberto Pavia Lopez
Kiran Philip
Johnny Wu
Erin S. Mackinnon
机构：
[1] University of Toronto and the Canadian Collaborative Research Network,Department of Medicine
[2] Amgen Canada Inc.,ICT Department
[3] Interventional Cardiology,Departments of Medicine and of Laboratory Medicine
[4] King Fahad Military Medical City,Division of Cardiology
[5] Centre Hospitalier Universitaire de Québec-Université Laval,Centre for Cardiovascular Innovation, Division of Cardiology, Department of Medicine
[6] Clinica de Occidente – Angiografia de Occidente,Clinical and Interventional Cardiology
[7] Hospital Universitario San Ignacio,undefined
[8] Pontificia Universidad Javeriana,undefined
[9] University of British Columbia,undefined
[10] Clinical and Interventional Research,undefined
[11] Cardiovascular Center Chapalita,undefined
[12] Centro Medico ABC,undefined
[13] Amgen Inc.,undefined
来源：
Cardiology and Therapy | 2023年 / 12卷
关键词：
Atherosclerotic cardiovascular disease (ASCVD); Evolocumab; Familial hypercholesterolemia (FH); Low-density lipoprotein cholesterol (LDL-C); Proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：703 / 722
页数：19
相关论文
共 50 条
  • [1] Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study
    Gupta, Milan
    Wani, Rajvi J.
    Al Faraidy, Khalid
    Bergeron, Jean
    Contreras, Eduardo
    Pena, Angel Alberto Garcia
    Mancini, G. B. John
    Padilla, Francisco
    Lopez, Abel Alberto Pavia
    Philip, Kiran
    Wu, Johnny
    Mackinnon, Erin S.
    CARDIOLOGY AND THERAPY, 2023, 12 (04) : 703 - 722
  • [2] Real-World Insights Into Evolocumab Use in Patients With Hyperlipidemia: Canadian Analysis From the ZERBINI Study
    Gupta, Milan
    Mancini, G. B. John
    Wani, Rajvi J.
    Ahooja, Vineeta
    Bergeron, Jean
    Manjoo, Priya
    Pandey, A. Shekhar
    Reiner, Maureen
    Beltran, Johnny
    Oliveira, Thiago
    Mackinnon, Erin S.
    CJC OPEN, 2022, 4 (06) : 558 - 567
  • [3] Real-World Application of Evolocumab Among Patients with Hyperlipidemia in Korea: A Multicenter Prospective Study
    Kim, Min Chul
    Lee, Seung Hun
    Ahn, Joon Ho
    Lim, Yongwhan
    Park, Kyung-il
    Kim, Choongki
    Ahn, Jong-Hwa
    Jeong, JinSeon
    Lee, Hojoon
    Kang, Woong Chol
    CARDIOLOGY AND THERAPY, 2024, 13 (04) : 695 - 706
  • [4] Treatment algorithm for multiple myeloma: Real-world insights across five European countries
    Rocci, A.
    Bulger, P.
    de Pinillos, A. Martinez
    Nasuti, P.
    Anger, C.
    Manuguid, F.
    ANNALS OF ONCOLOGY, 2018, 29
  • [5] Understanding remission in real-world lupus patients across five European countries
    Schneider, M.
    Mosca, M.
    Pego-Reigosa, J. M.
    Hachulla, E.
    Teh, L-S
    Perna, A.
    Koscielny, V.
    Pike, J.
    Lobosco, S.
    Apolone, G.
    LUPUS, 2016, 25 (05) : 505 - 512
  • [6] Multizonal observational study conducted by clinical practitioners on evolocumab use in subjects with hyperlipidemia in Saudi Arabia and Kuwait: Results from the ZERBINI study
    Al Faraidy, Khalid
    Akbar, Mousa
    Shehri, Mohamed
    Aljarallah, Mohammad
    Abdin Hussein, Gamal
    Dashti, Raja
    Al Qudaimi, Ahmad
    Al Nouri, Fahad
    Awan, Zuhier
    Essam, Ahmed
    Emara, Alaa
    PLOS ONE, 2023, 18 (01):
  • [7] Adverse Reactions to Evolocumab: Analysis of Real-World Data from EudraVigilance
    Calapai, Fabrizio
    Mannucci, Carmen
    Curro, Mariaconcetta
    Cardia, Luigi
    Esposito, Emanuela
    Calapai, Gioacchino
    Ammendolia, Ilaria
    PHARMACEUTICALS, 2024, 17 (03)
  • [8] Analysis of the characteristics of IgA nephropathy patients using real-world data from five European countries
    Csomor, Philipp
    Hurtado, Tucker
    Dudzenski, Christopher
    Pollet, Charlotte
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [9] Analysis of the characteristics of IgA nephropathy patients using real-world data from five European countries
    Csomor, Philipp
    Hurtado, Tucker
    Dudzenski, Christopher
    Pollet, Charlotte
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2125 - I2125
  • [10] Analysis of current real-world management of IgAN in five European countries
    Csomor, Philipp
    Hurtado, Tucker
    Dudzenski, Christopher
    Pollet, Charlotte
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2123 - I2123
12345